Nanostring technologies, INC.:1165300 [17-047991]

Ended Awarded

Contract number
HHSN26100019
Awardee
Awarding agency
Obligated
$10,892

Award facts

Contract value 100% obligated
$10,892.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
339999 All Other Miscellaneous Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Seattle, WA 98109, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute awarded a $10,892 firm fixed-price BPA (Blanket Purchase Agreement) call to Nanostring Technologies, Inc. on June 27, 2017, with a completion date of July 27, 2017. This contract represents a delivery order against an existing blanket purchase agreement and was performed at Nanostring's Seattle, Washington facility. No set-aside designation was applied to this award. Nanostring Technologies is a publicly traded provider of advanced genomic analysis platforms and life science tools, specializing in multiplexed digital detection technologies such as the nCounter Analysis Systems and GeoMx Digital Spatial Profiler for translational research and molecular diagnostics applications.

The award reflects the National Cancer Institute's procurement of specialized genomic analysis capabilities from Nanostring, consistent with the vendor's established role as a supplier of laboratory equipment, reagents, assays, and testing services to federal biomedical research programs. Nanostring has demonstrated extensive experience across multiple federal agencies including the National Institutes of Health, Department of Veterans Affairs, Department of Agriculture, Department of Defense, and U.S. Geological Survey, delivering genomic analysis systems, codesets, reagent kits, and consumables to support complex biological and disease research initiatives.

Quick answers

Who was awarded contract HHSN26100019?

HHSN26100019 was awarded to Nanostring Technologies, Inc. by National Cancer Institute (National Institutes of Health) on June 27, 2017.

How much is contract HHSN26100019 worth?

The government has obligated $10,892 on HHSN26100019.

Is contract HHSN26100019 an order under another contract?

Yes. HHSN26100019 is a BPA call under HHSN263201400050B, a blanket purchase agreement.

Was contract HHSN26100019 competed?

The extent of competition for HHSN26100019 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award